{"id":"NCT02741245","sponsor":"Organon and Co","briefTitle":"A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)","officialTitle":"A Phase III, Randomized, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of MK-0653H in Japanese Patients With Hypercholesterolemia.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-09","primaryCompletion":"2017-01-18","completion":"2017-01-18","firstPosted":"2016-04-18","resultsPosted":"2018-03-09","lastUpdate":"2024-05-16"},"enrollment":321,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Ezetimibe 10 mg","otherNames":[]},{"type":"DRUG","name":"Rosuvastatin 2.5 mg","otherNames":[]},{"type":"DRUG","name":"Placebo for Ezetimibe","otherNames":[]},{"type":"DRUG","name":"Placebo for Rosuvastatin","otherNames":[]}],"arms":[{"label":"Ezetimibe 10 mg","type":"ACTIVE_COMPARATOR"},{"label":"Rosuvastatin 2.5 mg","type":"ACTIVE_COMPARATOR"},{"label":"Rosuvastatin 5.0 mg","type":"ACTIVE_COMPARATOR"},{"label":"Ezetimibe 10 mg+ Rosuvastatin 2.5 mg","type":"EXPERIMENTAL"},{"label":"Ezetimibe 10 mg+ Rosuvastatin 5.0 mg","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the efficacy and safety and tolerability of 2 dose levels of MK-0653H in Japanese participants. The primary hypotheses are that the administration of MK-0653H is safe and tolerable and that MK-0653H is superior to single entity of Ezetimibe and Rosuvastatin in percent reduction from baseline in low-density lipoprotein-cholesterol (LDL-C) after 12 weeks of treatment.","primaryOutcome":{"measure":"Percentage Change From Baseline in Low-density Lipoprotein-cholesterol (LDL-C)","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Ezetimibe 10 mg","deltaMin":-18.7,"sd":null},{"arm":"Rosuvastatin 2.5 mg","deltaMin":-39.8,"sd":null},{"arm":"Rosuvastatin 5.0 mg","deltaMin":-47.2,"sd":null},{"arm":"Ezetimibe 10 mg+ Rosuvastatin 2.5 mg","deltaMin":-54.6,"sd":null},{"arm":"Ezetimibe 10 mg+ Rosuvastatin 5.0 mg","deltaMin":-60.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG001 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG004","p":"<0.001"},{"comp":"OG002 vs OG004","p":"<0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":16},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["Nasopharyngitis"]}}